BioMarin Pharmaceutical Inc.
BMRNBiotechnology
$57.49+2.66%As of Oct 29vs prior close
- Market cap
- $11.1B
- P/E (TTM)
- 151.3×
- P/E (FY1)
- 16.4×
- From 52W high
- −18.15%
- EPS (LTM)
- $0.39
- Revenue (LTM)
- $3.4B
- Net margin
- 2.14%
- Dividend yield
- 0.00%
Nomior Score
78
Discounted QualityTop 3% of the scored universe
Growth69
Quality77
Value68
Momentum65
Resilience55
Growth
+12.49%revenue a year over 9 fiscal years
YE16 $1.1BLTM $3.4B
Connections
Revenue to profitQ2 YE26
5% of revenue became net profit, down 25 pts on a year.
Who owns it
2funds, 3 tracked portfolios